CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
Revenues:
Products and services	$ 0	$ 42,995	$ 16,031	$ 147,711
Patent licensing	0	1,078,500	693,500	2,051,034
Total Revenues	0	1,121,495	709,531	2,198,745
Cost of revenues:
Products and services	0	79,322	8,256	238,729
Patent licensing and litigation costs	112,500	117,185	337,500	342,774
Contingent legal fees and expenses	5,261	338,630	292,156	642,006
Selling and administrative	176,366	185,481	657,549	548,968
Research and related expenditures	70,542	93,786	253,396	261,594
Total operating costs and expenses	364,669	814,404	1,548,857	2,034,071
Operating income (loss) before other income and provision for income taxes	(364,669)	307,091	(839,326)	164,674
Other income:
Other income	800	0	800	0
Other income	800	0	800	0
Income (loss) before provision for income taxes	(363,869)	307,091	(838,526)	164,674
Income tax expense	0	(31,350)	0	(31,350)
Income (loss) for the period	$ (363,869)	$ 275,741	$ (838,526)	$ 133,324
Income (loss) per common share - basic	$ (0.00)	$ 0.00	$ (0.00)	$ 0.00
Income (loss) per common share - diluted	$ (0.00)	$ 0.00	$ (0.00)	$ 0.00
Weighted average common shares outstanding
Basic	293,678,330	293,328,330	293,564,512	293,328,330
Diluted	293,678,330	294,164,274	293,564,512	294,135,318